SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Melchiorre Maria Gabriella)
 

Sökning: WFRF:(Melchiorre Maria Gabriella) > The prevalence of s...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005062naa a2200493 4500
001oai:DiVA.org:miun-25890
003SwePub
008150921s2015 | |||||||||||000 ||eng|
0247 a https://urn.kb.se/resolve?urn=urn:nbn:se:miun:diva-258902 URI
0247 a https://doi.org/10.1186/s12913-015-1089-42 DOI
040 a (SwePub)miun
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
1001 a Stankuniene, Aurimau Lithuanian Univ Hlth Sci, Dept Drug Technol & Social Pharm, Kaunas, Lithuania4 aut
2451 0a The prevalence of self-reported underuse of medications due to cost for the elderly: results from seven European urban communities
264 c 2015-09-26
264 1b Springer Science and Business Media LLC,c 2015
338 a electronic2 rdacarrier
520 a Background: The aim of this study was to evaluate the prevalence of self-reported underuse of medications due toprocurement costs amongst older persons from seven European urban communities.Methods: The data were collected in a cross-sectional study (“ABUEL, Elder abuse: A multinational prevalencesurvey”) in 2009. Randomly selected people aged 60–84 years (n = 4,467) from seven urban communities: Stuttgart(Germany), Athens (Greece), Ancona (Italy), Kaunas (Lithuania), Porto (Portugal), Granada (Spain) and Stockholm(Sweden) were interviewed. Response rate - 45.2 %. Ethical permission was received in each country.Results: The results indicate that 3.6 % (n = 162) of the respondents self-reported refraining from buying prescribedmedications due to cost. The highest prevalence of this problem was identified in Lithuania (15.7 %, n = 99) and Portugal(4.3 %, n = 28). Other countries reported lower percentages of refraining from buying medications (Germany – 2.0 %,Italy – 1.6 %, Sweden – 1.0 %, Greece – 0.6 %, Spain – 0.3 %). Females refrained more often from buying medicationsthan males (2.6 % vs. 4.4 %, p < 0.0001). The prevalence of this refraining tended to increase with economic hardship.Discussion: These differences between countries can be only partly described by the financing of health-care systems.In spite of the presence of cost reimbursement mechanisms, patients need to make co-payments (or in some cases topay the full price) for prescribed medications. This indicates that the purchasing power of people in 10.1186/s12913-015-1089-4 the particular country can play a major role and be related with the economic situation in the country. Lithuania,which has reported the highest refrain rates, had the lowest gross domestic product (at the time of conducting thisstudy) of all participating countries in the study.Conclusions: Refraining from buying the prescribed medications due to cost is a problem for women and men inrespect to ageing people in Europe. Prevalence varies by country, sex, and economic hardship.Keywords: Ageing, Accessibility, Medications, Europe, ABUEL
653 a Ageing
653 a Accessibility
653 a Medications
653 a Europe
653 a ABUEL
7001 a Stankunas, Mindaugasu Lithuanian Univ Hlth Sci, Dept Hlth Management, Kaunas, Lithuania4 aut
7001 a Lindert, Juttau Univ Emden, Dept Publ Hlth, Emden, Germany4 aut
7001 a Avery, Marku Griffith Univ, Sch Med, Ctr Hlth Innovat, Hlth Serv Management Dept, Gold Coast, Qld, Australia4 aut
7001 a Mikalauskiene, Ritau Lithuanian Univ Hlth Sci, Dept Drug Technol & Social Pharm, Kaunas, Lithuania4 aut
7001 a Melchiorre, Maria Gabriellau Italian Natl Inst Hlth & Sci Aging INRCA, Ctr Socio Econ Res Ageing, Sci Technol Area, Ancona, Italy4 aut
7001 a Torres-Gonzalez, Franciscou Univ Granada, Ctr Invest Biomed Red Salud Mental CIBERSAM, Granada, Spain4 aut
7001 a Ioannidi-Kapolou, Elisabethu Natl Sch Publ Hlth, Dept Sociol, Athens, Greece4 aut
7001 a Barros, Henriqueu Univ Porto, Fac Med, Dept Hyg & Epidemiol, P-4100 Oporto, Portugal4 aut
7001 a Savickas, Arunasu Lithuanian Univ Hlth Sci, Dept Drug Technol & Social Pharm, Kaunas, Lithuania4 aut
7001 a Radziunas, Raimondasu Lithuanian Univ Hlth Sci, Dept Drug Technol & Social Pharm, Kaunas, Lithuania4 aut
7001 a Soares, Joaquim JFu Mittuniversitetet,Avdelningen för hälsovetenskap4 aut0 (Swepub:miun)joasoa
7102 a Lithuanian Univ Hlth Sci, Dept Drug Technol & Social Pharm, Kaunas, Lithuaniab Lithuanian Univ Hlth Sci, Dept Hlth Management, Kaunas, Lithuania4 org
7730 t BMC Health Services Researchd : Springer Science and Business Media LLCg 15, s. 1-8q 15<1-8x 1472-6963
8564 u https://doi.org/10.1186/s12913-015-1089-4y Fulltext
8564 u https://miun.diva-portal.org/smash/get/diva2:855626/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 u https://bmchealthservres.biomedcentral.com/track/pdf/10.1186/s12913-015-1089-4
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:miun:diva-25890
8564 8u https://doi.org/10.1186/s12913-015-1089-4

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy